• Users Online: 50
  • Print this page
  • Email this page
CASE REPORT
Year : 2021  |  Volume : 5  |  Issue : 3  |  Page : 132-134

Elbasvir/grazoprevir treatment in a hemodialysis patient with hepatitis C Virus Genotype 2a Infection, not responded to sofosbuvir/daclatasvir combination therapy


1 Department of Dialysis, Azzawiyah Kidney Hospital; Medical Faculty, Zawia University, Zawia, Libya
2 Medical Faculty, Zawia University, Zawia; Department of Dialysis, Sabratha Teaching Hospital, Sabratha-, Libya

Correspondence Address:
Dr. Marwa Belgasem Elmelodi
Department of Dialysis Azzawiyah Kidney Hospital, University of Zawia,Omer Moktar Street 110, Zawia
Libya
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ljms.ljms_41_21

Rights and Permissions

Since 2017, direct-acting antivirals (DAAs) are the first-line treatment for patients with chronic hepatitis C virus (HCV) infection. In hemodialysis (HD) patients, however, a small percentage of patients failed to respond, and the data for the treatment of DAAs for such patients with HCV are lacking. Herein, we report a 57-year-old Libyan female patient on regular HD therapy for 18 years who did not achieved HCV clearance 12 weeks after the treatment with sofosbuvir/daclatasvir. Later, she was treated with elbasvir/grazoprevir (EBR/GZR) for 12 weeks and achieved a sustained virological response at the end of the treatment (12 weeks) and 12 months after the end of the treatment. No obvious side effects were reported during the treatment. Thus, EBR/GZR was effective and safe in this hemodialyzed patient with HCV genotype 2b infection who was failed to respond to12 week-treatment with sofosbuvir/daclatasvir combination.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed212    
    Printed10    
    Emailed0    
    PDF Downloaded24    
    Comments [Add]    

Recommend this journal